OBJECTIVES: To examine the association between depression, antidepressant use, and bone health in older adults and the implications for treatment. DESIGN: Systematic review. SETTING: All studies that measured depression or antidepressant exposure and bone mineral density (BMD). PARTICIPANTS: Adults aged 60 and older. MEASUREMENTS: Age, site of BMD measurement using dual-energy X-ray absorptiometry (DXA), measure of depression or depressive symptoms, association between BMD changes, and depression or antidepressant use. RESULTS: Nineteen observational studies met the final inclusion criteria; no experimental studies were found. Several cross-sectional and longitudinal studies found that depression or depressive symptoms were associated with a decrease in BMD. Few studies and only two longitudinal studies addressed the association between serotonin reuptake inhibitor (SRI) antidepressant use and a decrease in BMD and they had conflicting results. CONCLUSION: Depression and depressive symptoms are associated with low bone mass and accelerated bone loss in older adults; putative mechanisms underlying this relationship are discussed. There is insufficient evidence that SRI antidepressants adversely affect bone health. Thus, a change in current recommendations for the use of antidepressants in older adults is not justified at the present time. Given the high public health significance of this question, more studies are required to determine whether (and in whom) antidepressants may be deleterious for bone health.
OBJECTIVES: To examine the association between depression, antidepressant use, and bone health in older adults and the implications for treatment. DESIGN: Systematic review. SETTING: All studies that measured depression or antidepressant exposure and bone mineral density (BMD). PARTICIPANTS: Adults aged 60 and older. MEASUREMENTS: Age, site of BMD measurement using dual-energy X-ray absorptiometry (DXA), measure of depression or depressive symptoms, association between BMD changes, and depression or antidepressant use. RESULTS: Nineteen observational studies met the final inclusion criteria; no experimental studies were found. Several cross-sectional and longitudinal studies found that depression or depressive symptoms were associated with a decrease in BMD. Few studies and only two longitudinal studies addressed the association between serotonin reuptake inhibitor (SRI) antidepressant use and a decrease in BMD and they had conflicting results. CONCLUSION:Depression and depressive symptoms are associated with low bone mass and accelerated bone loss in older adults; putative mechanisms underlying this relationship are discussed. There is insufficient evidence that SRI antidepressants adversely affect bone health. Thus, a change in current recommendations for the use of antidepressants in older adults is not justified at the present time. Given the high public health significance of this question, more studies are required to determine whether (and in whom) antidepressants may be deleterious for bone health.
Authors: J Brent Richards; Alexandra Papaioannou; Jonathan D Adachi; Lawrence Joseph; Heather E Whitson; Jerilynn C Prior; David Goltzman Journal: Arch Intern Med Date: 2007-01-22
Authors: Jane A Cauley; Robin L Fullman; Katie L Stone; Joseph M Zmuda; Douglas C Bauer; Elizabeth Barrett-Connor; Kristine Ensrud; Edith M C Lau; Eric S Orwoll Journal: Osteoporos Int Date: 2005-05-11 Impact factor: 4.507
Authors: N Bonnet; P Bernard; H Beaupied; J C Bizot; F Trovero; D Courteix; C L Benhamou Journal: Toxicol Appl Pharmacol Date: 2007-02-23 Impact factor: 4.219
Authors: B I Gustafsson; L Thommesen; A K Stunes; K Tommeras; I Westbroek; H L Waldum; K Slørdahl; M V Tamburstuen; J E Reseland; U Syversen Journal: J Cell Biochem Date: 2006-05-01 Impact factor: 4.429
Authors: Charles F Reynolds; Mary Amanda Dew; Bruce G Pollock; Benoit H Mulsant; Ellen Frank; Mark D Miller; Patricia R Houck; Sati Mazumdar; Meryl A Butters; Jacqueline A Stack; Mary Ann Schlernitzauer; Ellen M Whyte; Ariel Gildengers; Jordan Karp; Eric Lenze; Katalin Szanto; Salem Bensasi; David J Kupfer Journal: N Engl J Med Date: 2006-03-16 Impact factor: 91.245
Authors: U Schweiger; M Deuschle; A Körner; C H Lammers; J Schmider; U Gotthardt; F Holsboer; I Heuser Journal: Am J Psychiatry Date: 1994-11 Impact factor: 18.112
Authors: Melanie Haffner-Luntzer; Sandra Foertsch; Verena Fischer; Katja Prystaz; Miriam Tschaffon; Yvonne Mödinger; Chelsea S Bahney; Ralph S Marcucio; Theodore Miclau; Anita Ignatius; Stefan O Reber Journal: Proc Natl Acad Sci U S A Date: 2019-04-04 Impact factor: 11.205
Authors: Eric J Lenze; Alex Ramsey; Patrick J Brown; Charles F Reynolds; Benoit H Mulsant; Helen Lavretsky; Steven P Roose Journal: Am J Geriatr Psychiatry Date: 2016-07-29 Impact factor: 4.105
Authors: Kerri S Rawson; David Dixon; Roberto Civitelli; Tim R Peterson; Benoit H Mulsant; Charles F Reynolds; Eric J Lenze Journal: J Am Geriatr Soc Date: 2017-05-26 Impact factor: 5.562
Authors: I Carrière; A Farré; J Norton; M Wyart; C Tzourio; P Noize; K Pérès; A Fourrier-Réglat; M L Ancelin Journal: Osteoporos Int Date: 2016-06-16 Impact factor: 4.507